Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.

Wang, Aihong; Zhao, Weibo; Xu, Zhangrong; Gu, Jianwen

Wang, Aihong; Zhao, Weibo; Xu, Zhangrong; Gu, Jianwen.

Wang A; Department of Endocrinology, PLA Strategic Support Force Characteristic Medical Center (The 306th Hospital of PLA), Beijing, China. Electronic address: wah306@sohu.com.
Zhao W; Department of Endocrinology, PLA Strategic Support Force Characteristic Medical Center (The 306th Hospital of PLA), Beijing, China.
Xu Z; Department of Endocrinology, PLA Strategic Support Force Characteristic Medical Center (The 306th Hospital of PLA), Beijing, China.
Gu J; Prevention and Control Group of COVID-19, PLA Strategic Support Force Characteristic Medical Center, Beijing, China. Electronic address: gujianwen5000@sina.com.

Diabetes Res Clin Pract ; 162: 108118, 2020 04.

Article in English | MEDLINE | ID: covidwho-9935

Subject(s)

Betacoronavirus; Blood Glucose/metabolism; Coronavirus Infections/complications; Diabetes Complications/prevention & control; Diabetes Mellitus; Pneumonia, Viral/complications; COVID-19; China/epidemiology; Coronavirus Infections/epidemiology; Diabetes Mellitus/drug therapy; Disease Outbreaks; Humans; Pandemics; Pneumonia, Viral/epidemiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Blood Glucose / Coronavirus Infections / Diabetes Complications / Diabetes Mellitus / Betacoronavirus Type of study: Observational study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google